Cover Image
Market Research Report

Asia Pacific Pneumonia Vaccines Market 2019-2025

Published by KBV Research Product code 888289
Published Content info 103 Pages
Delivery time: 1-2 business days
Price
Back to Top
Asia Pacific Pneumonia Vaccines Market 2019-2025
Published: June 30, 2019 Content info: 103 Pages
Description

The Asia Pacific Pneumonia Vaccines Market would witness market growth of 6.2% CAGR during the forecast period (2019-2025).

Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, virus, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Pneumonia results in inflammation in the air sacs (known as alveoli) of the lungs thereby filling the alveoli with fluid (pus cells), thus causing breathing problems. Pneumococcal disease is common in young children, but older adults are at the greatest risk of serious pneumococcal infections and even death. Pneumonia vaccines are primarily administered to children less than 2-years old and adults aged 65 years and older. This vaccine helps individuals provide immunization against 13 types of pneumococcal bacteria that cause infection in the lungs.

The key factors that drive the growth of the pneumonia vaccine market include an increase in the prevalence of pneumonia across the globe, rise in government focus on immunization programs for pneumonia, and introduction of novel pneumococcal vaccines such as PCV10. However, longer timelines required for pneumonia vaccine production and high costs associated with the development of such vaccines restrain the market growth.

Based on Vaccine Type, the market is segmented into Pneumococcal conjugate vaccine (PCV) and Pneumococcal polysaccharide vaccine (PPSV/PPV). Based on Product Type, the market is segmented into Prevnar 13, Synflorix and Pneumovax23. According to sector, the market is segmented into Public sector and Private sector. Based on Distribution Channel, the market is further segmented into Distribution partner companies, Non-governmental Organizations (NGO) and Government Authorities. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Glaxosmithkline Plc. (GSK), LG Corporation, Panacea Biotec Limited, Pfizer, Inc., Pnuvax Incorporated, Poonawalla Investments & Industries Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd., SK Holdings Co., Ltd., Walvax Biotechnology Co., Ltd. And MERCK & CO., Inc.

Scope of the Study

Market Segmentation:

By Vaccine Type

  • Pneumococcal conjugate vaccine (PCV)
  • Pneumococcal polysaccharide vaccine (PPSV/PPV)

By Product Type

  • Prevnar 13
  • Synflorix
  • Pneumovax23

By Sector

  • Public sector
  • Private sector

By Distribution Channel

  • Distribution partner companies
  • Non-governmental Organizations (NGO)
  • Government Authorities

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • Glaxosmithkline Plc. (GSK)
  • LG Corporation
  • Panacea Biotec Limited
  • Pfizer, Inc.
  • Pnuvax Incorporated
  • Poonawalla Investments & Industries Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co., Ltd.
  • SK Holdings Co., Ltd.
  • Walvax Biotechnology Co., Ltd.
  • Merck & Co., Inc.
Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific Pneumonia Vaccines Market, by Vaccine Type
    • 1.4.2 Asia Pacific Pneumonia Vaccines Market, by Product Type
    • 1.4.3 Asia Pacific Pneumonia Vaccines Market, by Sector
    • 1.4.4 Asia Pacific Pneumonia Vaccines Market, by Distribution Channel
    • 1.4.5 Asia Pacific Pneumonia Vaccines Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Asia Pacific Pneumonia Vaccines Market by Type

  • 3.1 Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Market by Region
  • 3.2 Asia Pacific Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region

Chapter 4. Asia Pacific Pneumonia Vaccines Market by Product Type

  • 4.1 Asia Pacific Prevnar 13 Market by Region
  • 4.2 Asia Pacific Synflorix Market by Region
  • 4.3 Asia Pacific Pneumovax 23 Market by Region

Chapter 5. Asia Pacific Pneumonia Vaccines Market by Sector

  • 5.1 Asia Pacific Private sector Market by Region
  • 5.2 Asia Pacific Public sector Market by Region

Chapter 6. Asia Pacific Pneumonia Vaccines Market by Distribution Channel

  • 6.1 Asia Pacific Distribution Partner Companies Market by Region
  • 6.2 Asia Pacific Non-Governmental Organizations (NGO) Market by Region
  • 6.3 Asia Pacific Government Authorities Market by Region

Chapter 7. Asia Pacific Pneumonia Vaccines Market by Region

  • 7.1 China Pneumonia Vaccines Market
    • 7.1.1 China Pneumonia Vaccines Market by Type
    • 7.1.2 China Pneumonia Vaccines Market by Product Type
    • 7.1.3 China Pneumonia Vaccines Market by Sector
    • 7.1.4 China Pneumonia Vaccines Market by Distribution Channel
  • 7.2 Japan Pneumonia Vaccines Market
    • 7.2.1 Japan Pneumonia Vaccines Market by Type
    • 7.2.2 Japan Pneumonia Vaccines Market by Product Type
    • 7.2.3 Japan Pneumonia Vaccines Market by Sector
    • 7.2.4 Japan Pneumonia Vaccines Market by Distribution Channel
  • 7.3 India Pneumonia Vaccines Market
    • 7.3.1 India Pneumonia Vaccines Market by Type
    • 7.3.2 India Pneumonia Vaccines Market by Product Type
    • 7.3.3 India Pneumonia Vaccines Market by Sector
    • 7.3.4 India Pneumonia Vaccines Market by Distribution Channel
  • 7.4 South Korea Pneumonia Vaccines Market
    • 7.4.1 South Korea Pneumonia Vaccines Market by Type
    • 7.4.2 South Korea Pneumonia Vaccines Market by Product Type
    • 7.4.3 South Korea Pneumonia Vaccines Market by Sector
    • 7.4.4 South Korea Pneumonia Vaccines Market by Distribution Channel
  • 7.5 Singapore Pneumonia Vaccines Market
    • 7.5.1 Singapore Pneumonia Vaccines Market by Type
    • 7.5.2 Singapore Pneumonia Vaccines Market by Product Type
    • 7.5.3 Singapore Pneumonia Vaccines Market by Sector
    • 7.5.4 Singapore Pneumonia Vaccines Market by Distribution Channel
  • 7.6 Malaysia Pneumonia Vaccines Market
    • 7.6.1 Malaysia Pneumonia Vaccines Market by Type
    • 7.6.2 Malaysia Pneumonia Vaccines Market by Product Type
    • 7.6.3 Malaysia Pneumonia Vaccines Market by Sector
    • 7.6.4 Malaysia Pneumonia Vaccines Market by Distribution Channel
  • 7.7 Rest of Asia Pacific Pneumonia Vaccines Market
    • 7.7.1 Rest of Asia Pacific Pneumonia Vaccines Market by Type
    • 7.7.2 Rest of Asia Pacific Pneumonia Vaccines Market by Product Type
    • 7.7.3 Rest of Asia Pacific Pneumonia Vaccines Market by Sector
    • 7.7.4 Rest of Asia Pacific Pneumonia Vaccines Market by Distribution Channel

Chapter 8. Company Profiles

  • 8.1 GLAXOSMITHKLINE PLC (GSK)
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.1 Recent strategies and developments:
      • 8.1.1.1 Collaboration, partnerships and agreements:
      • 8.1.1.2 Expansion:
    • 8.1.2 SWOT Analysis
  • 8.2 LG Corporation (LG Chemicals Ltd.)
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 SWOT Analysis
  • 8.3 Panacea Biotec Limited
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Collaboration, partnerships and agreements:
    • 8.3.6 SWOT Analysis
  • 8.4 Pfizer, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expense
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Collaboration, partnerships and agreements:
      • 8.4.5.2 Product launch:
    • 8.4.6 SWOT Analysis
  • 8.5 PnuVax Incorporated
    • 8.5.1 Company Overview
  • 8.6 Poonawalla Investments & Industries Pvt. Ltd. (Serum Institute of India Pvt. Ltd.)
    • 8.6.1 Company Overview
  • 8.7 Shenzhen Kangtai Biological Products Co., Ltd. (Beijing Minhai Biotechnology Corporation Limited)
    • 8.7.1 Company Overview
  • 8.8 SK Holdings Co., Ltd. (SK Bioscience, Inc.)
    • 8.8.1 Company overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental and Regional Analysis
    • 8.8.4 Research & Development Expenses
  • 8.9 Walvax Biotechnology Co., Ltd.
    • 8.9.1 Company Overview
    • 8.9.2 Recent strategies and developments:
      • 8.9.2.1 Product launch:
  • 8.1 Merck & Co., Inc.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Segmental and Regional Analysis
    • 8.10.4 Research & Development Expenses
    • 8.10.5 Recent strategies and developments:
      • 8.10.5.1 Collaboration, partnerships and agreements:
      • 8.10.5.2 Product launch:
    • 8.10.6 SWOT Analysis

LIST OF TABLES

  • TABLE 1 ASIA PACIFIC PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 2 ASIA PACIFIC PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 3 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 4 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 5 ASIA PACIFIC PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 6 ASIA PACIFIC PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 7 ASIA PACIFIC PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 8 ASIA PACIFIC PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 9 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 10 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 11 ASIA PACIFIC PREVNAR 13 MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 12 ASIA PACIFIC PREVNAR 13 MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 13 ASIA PACIFIC SYNFLORIX MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 14 ASIA PACIFIC SYNFLORIX MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 15 ASIA PACIFIC PNEUMOVAX 23 MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 16 ASIA PACIFIC PNEUMOVAX 23 MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 17 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 18 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 19 ASIA PACIFIC PRIVATE SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 20 ASIA PACIFIC PRIVATE SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 21 ASIA PACIFIC PUBLIC SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 22 ASIA PACIFIC PUBLIC SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 23 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 24 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 25 ASIA PACIFIC DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 26 ASIA PACIFIC DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 27 ASIA PACIFIC NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 28 ASIA PACIFIC NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 29 ASIA PACIFIC GOVERNMENT AUTHORITIES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 30 ASIA PACIFIC GOVERNMENT AUTHORITIES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 31 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 32 ASIA PACIFIC PNEUMONIA VACCINES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 33 CHINA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 34 CHINA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 35 CHINA PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 36 CHINA PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 37 CHINA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 38 CHINA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 39 CHINA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 40 CHINA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 41 CHINA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 42 CHINA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 43 JAPAN PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 44 JAPAN PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 45 JAPAN PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 46 JAPAN PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 47 JAPAN PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 48 JAPAN PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 49 JAPAN PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 50 JAPAN PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 51 JAPAN PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 52 JAPAN PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 53 INDIA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 54 INDIA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 55 INDIA PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 56 INDIA PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 57 INDIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 58 INDIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 59 INDIA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 60 INDIA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 61 INDIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 62 INDIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 63 SOUTH KOREA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 64 SOUTH KOREA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 65 SOUTH KOREA PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 66 SOUTH KOREA PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 67 SOUTH KOREA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 68 SOUTH KOREA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 69 SOUTH KOREA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 70 SOUTH KOREA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 71 SOUTH KOREA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 72 SOUTH KOREA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 73 SINGAPORE PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 74 SINGAPORE PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 75 SINGAPORE PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 76 SINGAPORE PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 77 SINGAPORE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 78 SINGAPORE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 79 SINGAPORE PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 80 SINGAPORE PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 81 SINGAPORE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 82 SINGAPORE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 83 MALAYSIA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 84 MALAYSIA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 85 MALAYSIA PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 86 MALAYSIA PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 87 MALAYSIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 88 MALAYSIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 89 MALAYSIA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 90 MALAYSIA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 91 MALAYSIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 92 MALAYSIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 93 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 94 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 95 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 96 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 97 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 98 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 99 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 100 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 101 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 102 REST OF ASIA PACIFIC PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 103 KEY INFORMATION - GLAXOSMITHKLINE PLC (GSK)
  • TABLE 104 KEY INFORMATION - LG CORPORATION
  • TABLE 105 KEY INFORMATION - PANACEA BIOTEC LIMITED
  • TABLE 106 KEY INFORMATION - PFIZER, INC.
  • TABLE 107 KEY INFORMATION - PNUVAX INCORPORATED
  • TABLE 108 KEY INFORMATION - POONAWALLA INVESTMENTS & INDUSTRIES PVT. LTD.
  • TABLE 109 KEY INFORMATION - SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
  • TABLE 110 KEY INFORMATION - SK HOLDINGS CO., LTD.
  • TABLE 111 KEY INFORMATION - WALVAX BIOTECHNOLOGY CO., LTD.
  • TABLE 112 KEY INFORMATION - MERCK & CO., INC.

LIST OF FIGURES

  • FIG 1 METHODOLOGY FOR THE RESEARCH
Back to Top